Insiders · Profile

Goldberg Mark Alan

Director at CRESCENT BIOPHARMA. Filing since 4 Mar 2016. CIK 0001532475

Company
Date
Role
Action
Shares
Amount
Of holding
4 Mar 2016
Director
Bought
10,397
$49.63K
945%
1 decision on file.